A Double‐Blind, Placebo‐Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360® as Acute Treatment for Chronic Migraine

Publisher: John Wiley & Sons Inc

E-ISSN: 1526-4610|55|1|101-116

ISSN: 0017-8748

Source: HEADACHE, Vol.55, Iss.1, 2015-01, pp. : 101-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content